Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China flag China · Delayed Price · Currency is CNY
25.02
-0.50 (-1.96%)
Nov 16, 2026, 3:00 PM CST

SHA:603334 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
254.79567.16166.78156.74217.7384.48
Trading Asset Securities
450300.14--0.830.18
Cash & Short-Term Investments
704.79867.3166.78156.74218.5784.66
Cash Growth
564.72%420.01%6.40%-28.29%158.18%118.62%
Accounts Receivable
317.25249.2244.82157.4181.05164.82
Other Receivables
17.133.9817.4618.5912.217.45
Receivables
334.35283.17262.29175.99193.26172.27
Inventory
512.06522.6242.01198.38104.24118.48
Other Current Assets
118.2254.2159.136.9996.6446.9
Total Current Assets
1,6691,727730.18568.1612.7422.31
Property, Plant & Equipment
476.32416.88433.02405.92254.98115.07
Goodwill
14.760.02----
Other Intangible Assets
100.1563.0759.7661.1450.8551.97
Long-Term Deferred Tax Assets
11.7711.668.864.716.064.21
Long-Term Deferred Charges
1.351.622.613.914.633.66
Other Long-Term Assets
3.844.822.337.668.611.87
Total Assets
2,2782,2251,2371,051937.82599.09

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
93.71168.29113.1157.4266.0261.24
Accrued Expenses
12.6829.3117.0127.8840.819.89
Short-Term Debt
254.9222.71173.39141.53159.28100.11
Current Portion of Long-Term Debt
8.655.197.290.2810.11-
Current Portion of Leases
-0.953.083.375.020.33
Current Income Taxes Payable
18.914.513.090.343.062.32
Current Unearned Revenue
46.5751.0827.4430.4435.3520.33
Other Current Liabilities
26.279.7714.1275.3853.519
Total Current Liabilities
461.69491.82358.53336.64373.14213.23
Long-Term Debt
-22.44106.3772.940.5-
Long-Term Leases
0.220.493.48-5.14-
Long-Term Unearned Revenue
16.6710.4811.3611.912.032.55
Long-Term Deferred Tax Liabilities
10.360.371.220.51.940.07
Other Long-Term Liabilities
24.21---1.661
Total Liabilities
513.14525.6480.96421.95424.41216.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
143.5143.5107.6107.6107.6105.79
Additional Paid-In Capital
956.67955.24189.71--87.29
Retained Earnings
659.32599.04458.48521.9405.82187.69
Total Common Equity
1,7591,698755.79629.5513.42380.77
Minority Interest
4.971.97---1.48
Shareholders' Equity
1,7641,700755.79629.5513.42382.25
Total Liabilities & Equity
2,2782,2251,2371,051937.82599.09

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
263.76251.78293.62218.09220.05100.44
Net Cash (Debt)
441.03615.52-126.83-61.34-1.48-15.79
Net Cash Growth
------
Net Cash Per Share
3.145.43-1.18-0.57-0.01-0.15
Filing Date Shares Outstanding
143.5143.5107.6143.5107.6106.16
Total Common Shares Outstanding
143.5143.5107.6143.5107.6106.16
Working Capital
1,2081,235371.64231.46239.56209.08
Book Value Per Share
12.2611.837.024.394.773.59
Tangible Book Value
1,6451,635696.03568.36462.57328.8
Tangible Book Value Per Share
11.4611.396.473.964.303.10
Buildings
-164.7572.0369.9525.0625.61
Machinery
-317.67128.96122.66103.9892.27
Construction In Progress
-25.2291.81262.7155.8527.76